近距离放射治疗市场－全球产业规模、份额、趋势、机会和预测，按产品、应用、剂量类型（高剂量率、低剂量率）、地区和竞争格局划分，2020-2030年预测

2024年全球近距离放射治疗市场规模为10.6亿美元，预计2030年将以7.4%的复合年增长率成长至16.3亿美元。近距离放射治疗是一种特殊的体内放射治疗方法，它将封装的放射源精确地放置在目标肿瘤内部或紧邻肿瘤的位置。这种高度局部化的治疗方法能够在最大限度减少周围健康组织辐射的同时，输送高剂量的辐射，从而提高治疗效果和患者预后。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球近距离放射治疗市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品分类（种子、施药器和后装器、电子近距离放射治疗）
  • 依应用领域（前列腺癌、妇科癌症、乳癌、其他）
  • 依剂量类型（高剂量率 (HDR)、低剂量率 (LDR)）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美近距离放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲近距离放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区近距离放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲近距离放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲近距离放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球近距离放射治疗市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Varian Medical Systems, Inc.
• Becton Dickinson & Company
• Elekta AB
• Isoray Medical, Inc.
• Eckert & Ziegler BEBIG
• iCAD, Inc.
• CIVCO Medical Solutions
• Theragenics Corporation
• Argon Medical Devices, Inc.
• Carl Zeiss Meditec AG

第十六章：策略建议

第17章调查会社について・免责事项

The Global Brachytherapy Market, valued at USD 1.06 Billion in 2024, is projected to experience a CAGR of 7.4% to reach USD 1.63 Billion by 2030. Brachytherapy is a specialized form of internal radiation therapy involving the precise placement of encapsulated radioactive sources directly within or immediately adjacent to a target tumor volume. This highly localized treatment delivers potent radiation doses while minimizing exposure to surrounding healthy tissues, thereby improving treatment efficacy and patient outcomes.

Key Market Drivers

The global brachytherapy market is significantly influenced by the increasing worldwide cancer burden. As cancer incidence continues its upward trajectory across various demographics, the demand for effective, localized treatment modalities like brachytherapy intensifies. According to the International Agency for Research on Cancer's Global Cancer Observatory, in February 2024, prostate cancer was the fourth most commonly occurring cancer worldwide with 1.5 million new cases in 2022.

Key Market Challenges

The substantial initial capital investment required for specialized equipment and facilities, coupled with the critical need for a highly skilled workforce, represents a significant impediment to the global brachytherapy market's expansion. This financial barrier limits the establishment of new brachytherapy centers and constrains existing facilities from upgrading to advanced technologies. The specialized nature of brachytherapy necessitates considerable upfront expenditure for afterloaders, treatment planning systems, and dedicated shielded rooms, presenting a challenging economic hurdle for healthcare providers aiming to integrate or enhance this treatment modality.

Key Market Trends

The emergence of artificial intelligence in brachytherapy treatment planning is significantly advancing the market by enhancing precision and efficiency. AI algorithms are streamlining complex tasks such as organ at risk contouring and dose optimization, which traditionally required considerable manual effort. The European Society for Radiotherapy and Oncology Congress Report from 2024 highlighted how AI-driven auto-segmentation reduced delineation time by half in cervical cancer brachytherapy and substantially decreased overall planning times with systems like BiCycle.

Key Market Players

• Varian Medical Systems, Inc.
• Becton Dickinson & Company
• Elekta AB
• Isoray Medical, Inc.
• Eckert & Ziegler BEBIG
• iCAD, Inc.
• CIVCO Medical Solutions
• Theragenics Corporation
• Argon Medical Devices, Inc.
• Carl Zeiss Meditec AG

Report Scope:

In this report, the Global Brachytherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Brachytherapy Market, By Product:

• Seeds
• Applicators & Afterloaders
• Electronic Brachytherapy

Brachytherapy Market, By Application:

• Prostate Cancer
• Gynecological Cancer
• Breast cancer
• Others

Brachytherapy Market, By Dosage Type:

• High-Dose Rate (HDR)
• Low-Dose Rate (LDR)

Brachytherapy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Brachytherapy Market.

Available Customizations:

Global Brachytherapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Brachytherapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Seeds, Applicators & Afterloaders, Electronic Brachytherapy)
  • 5.2.2. By Application (Prostate Cancer, Gynecological Cancer, Breast cancer, Others)
  • 5.2.3. By Dosage Type (High-Dose Rate (HDR), Low-Dose Rate (LDR))
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Brachytherapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Dosage Type
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Brachytherapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Dosage Type
  • 6.3.2. Canada Brachytherapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Dosage Type
  • 6.3.3. Mexico Brachytherapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Dosage Type

7. Europe Brachytherapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Dosage Type
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Brachytherapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Dosage Type
  • 7.3.2. France Brachytherapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Dosage Type
  • 7.3.3. United Kingdom Brachytherapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Dosage Type
  • 7.3.4. Italy Brachytherapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Dosage Type
  • 7.3.5. Spain Brachytherapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Dosage Type

8. Asia Pacific Brachytherapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Dosage Type
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Brachytherapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Dosage Type
  • 8.3.2. India Brachytherapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Dosage Type
  • 8.3.3. Japan Brachytherapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Dosage Type
  • 8.3.4. South Korea Brachytherapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Dosage Type
  • 8.3.5. Australia Brachytherapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Dosage Type

9. Middle East & Africa Brachytherapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Dosage Type
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Brachytherapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Dosage Type
  • 9.3.2. UAE Brachytherapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Dosage Type
  • 9.3.3. South Africa Brachytherapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Dosage Type

10. South America Brachytherapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Dosage Type
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Brachytherapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Dosage Type
  • 10.3.2. Colombia Brachytherapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Dosage Type
  • 10.3.3. Argentina Brachytherapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Dosage Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Brachytherapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Varian Medical Systems, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton Dickinson & Company
• 15.3. Elekta AB
• 15.4. Isoray Medical, Inc.
• 15.5. Eckert & Ziegler BEBIG
• 15.6. iCAD, Inc.
• 15.7. CIVCO Medical Solutions
• 15.8. Theragenics Corporation
• 15.9. Argon Medical Devices, Inc.
• 15.10. Carl Zeiss Meditec AG

16. Strategic Recommendations

17. About Us & Disclaimer